Tudor Financial Inc. Acquires 2,623 Shares of Veeva Systems Inc. $VEEV

Tudor Financial Inc. increased its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 497.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,150 shares of the technology company’s stock after acquiring an additional 2,623 shares during the period. Tudor Financial Inc.’s holdings in Veeva Systems were worth $559,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Empire Life Investments Inc. raised its stake in Veeva Systems by 21.1% during the fourth quarter. Empire Life Investments Inc. now owns 37,054 shares of the technology company’s stock worth $8,272,000 after acquiring an additional 6,453 shares in the last quarter. Czech National Bank acquired a new stake in shares of Veeva Systems in the 2nd quarter valued at $7,584,000. BNP Paribas boosted its stake in shares of Veeva Systems by 89.3% in the 4th quarter. BNP Paribas now owns 19,239 shares of the technology company’s stock valued at $4,308,000 after purchasing an additional 9,077 shares in the last quarter. ABN Amro Investment Solutions grew its holdings in shares of Veeva Systems by 28.4% in the 4th quarter. ABN Amro Investment Solutions now owns 76,809 shares of the technology company’s stock worth $17,146,000 after purchasing an additional 17,007 shares during the last quarter. Finally, East Coast Asset Management LLC. bought a new stake in shares of Veeva Systems in the 1st quarter worth about $1,665,000. Institutional investors own 88.20% of the company’s stock.

Veeva Systems Trading Up 1.2%

Shares of VEEV stock opened at $284.09 on Friday. Veeva Systems Inc. has a 1 year low of $148.05 and a 1 year high of $310.50. The firm’s 50 day moving average is $218.44 and its 200-day moving average is $187.34. The firm has a market capitalization of $46.15 billion, a price-to-earnings ratio of 46.73, a PEG ratio of 1.20 and a beta of 0.97.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings results on Wednesday, August 26th. The technology company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $2.23 by $0.12. Veeva Systems had a net margin of 29.34% and a return on equity of 14.25%. The business had revenue of $927.96 million during the quarter, compared to analyst estimates of $905.38 million. During the same quarter last year, the business posted $1.99 earnings per share. Veeva Systems’s revenue for the quarter was up 17.6% compared to the same quarter last year. Veeva Systems has set its FY 2027 guidance at 9.210-9.210 EPS and its Q3 2027 guidance at 2.330-2.340 EPS. On average, equities research analysts forecast that Veeva Systems Inc. will post 6.7 earnings per share for the current fiscal year.

Insider Buying and Selling at Veeva Systems

In other news, insider Thomas Schwenger sold 10,000 shares of the business’s stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $281.33, for a total transaction of $2,813,300.00. Following the completion of the sale, the insider owned 19,449 shares in the company, valued at $5,471,587.17. The trade was a 33.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 10.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on VEEV. Canaccord Genuity Group lifted their price target on shares of Veeva Systems from $220.00 to $260.00 and gave the company a “hold” rating in a report on Thursday, August 27th. Weiss Ratings upgraded shares of Veeva Systems from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, August 12th. Royal Bank Of Canada boosted their target price on Veeva Systems from $275.00 to $325.00 and gave the stock an “outperform” rating in a report on Thursday, August 27th. Guggenheim raised their price target on Veeva Systems from $276.00 to $310.00 and gave the company a “buy” rating in a report on Thursday, August 27th. Finally, Barclays lifted their price objective on Veeva Systems from $275.00 to $315.00 and gave the company an “overweight” rating in a research report on Thursday, August 27th. Nineteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $284.46.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Veeva raised its fiscal 2027 outlook, citing accelerating Vault CRM migrations, continued research-and-development investment, and growing momentum for Falcon AI. The improved outlook supports expectations for stronger revenue growth and profitability. VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast
• Positive Sentiment: Veeva launched Falcon Safety, an AI-focused product designed to streamline adverse-event management, giving investors another example of how the company is expanding its platform and monetizing AI capabilities. Veeva Launches Falcon Safety To Streamline Adverse Event Management
• Positive Sentiment: Analyst commentary remains favorable, including an upgrade reported earlier this week. Investor interest is also supported by the view that Veeva’s software and AI growth prospects remain attractive relative to more highly valued technology stocks. Veeva Systems Trading Up After Analyst Upgrade
• Neutral Sentiment: Veeva is scheduled to present at the Wells Fargo Healthcare Conference, potentially providing additional detail on customer demand, product adoption, and its updated outlook. Veeva to Present at Upcoming Investor Conferences
• Negative Sentiment: Market saturation remains a key risk: as Veeva expands within the life-sciences software market, sustaining its current growth rate could become more difficult. Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
• Negative Sentiment: Veeva’s exiting president sold 10,000 shares for approximately $2.8 million, representing about half of the executive’s direct stake before the transaction. Although the sale may reflect personal or transition-related factors, it could add modest insider-selling pressure. Veeva’s Exiting President Sold $2.8 Million in Stock

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.